Skip to main content
Clinical Trials/CTRI/2022/07/044417
CTRI/2022/07/044417
Not yet recruiting
Phase 2

A Clinical study to evaluate the efficacy of Shyamadi Agada in Cement Induced Irritant Contact Dermatitis

Dr Deepika J R0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Deepika J R
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Deepika J R

Eligibility Criteria

Inclusion Criteria

  • 1\) Patients between 16 to 60 years of age.
  • 2\) Patients with continuous exposure to cement for 1 year (i.e. chronic contact dermatitis).

Exclusion Criteria

  • 1\) Patients suffering from other systemic diseases that interfere in prognosis and treatment of disease.
  • 2\) Patients suffering from fatal diseases like skin carcinoma etc.
  • 3\) Patients who are under medication for chronic or any systemic illness.

Outcomes

Primary Outcomes

Not specified

Similar Trials